Matrixx Initiatives Withdraws Acquisition Offer for ProPhase Labs

[PR Newswire] – BRIDGEWATER, N.J., Feb. 5, 2013 /PRNewswire/ — Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, announced today that it has withdrawn the $1.60 per share offer … more

View todays social media effects on PRPH

View the latest stocks trending across Twitter. Click to view dashboard

See who ProPhase is hiring next, click here to view